These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 16338020)
1. Influence of viral hepatitis on HIV infection. Rockstroh JK J Hepatol; 2006; 44(1 Suppl):S25-7. PubMed ID: 16338020 [TBL] [Abstract][Full Text] [Related]
2. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. Rockstroh JK; Mocroft A; Soriano V; Tural C; Losso MH; Horban A; Kirk O; Phillips A; Ledergerber B; Lundgren J; J Infect Dis; 2005 Sep; 192(6):992-1002. PubMed ID: 16107951 [TBL] [Abstract][Full Text] [Related]
3. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy. Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069 [TBL] [Abstract][Full Text] [Related]
4. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients. Kumar R; Singla V; Kacharya Sk Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605 [TBL] [Abstract][Full Text] [Related]
5. The epidemiology and natural history of HIV/HBV and HIV/HCV co-infections. Mathews G; Bhagani S J HIV Ther; 2003 Nov; 8(4):77-84. PubMed ID: 14671504 [TBL] [Abstract][Full Text] [Related]
6. Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database. Petoumenos K; Ringland C; HIV Med; 2005 May; 6(3):155-63. PubMed ID: 15876281 [TBL] [Abstract][Full Text] [Related]
7. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Tedaldi EM; Baker RK; Moorman AC; Alzola CF; Furhrer J; McCabe RE; Wood KC; Holmberg SD; Clin Infect Dis; 2003 Feb; 36(3):363-7. PubMed ID: 12539079 [TBL] [Abstract][Full Text] [Related]
8. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study. Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study). Diop-Ndiaye H; Touré-Kane C; Etard JF; Lô G; Diaw P; Ngom-Gueye NF; Gueye PM; Ba-Fall K; Ndiaye I; Sow PS; Delaporte E; Mboup S J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596 [TBL] [Abstract][Full Text] [Related]
10. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy. Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection. Asmuth DM; Busch MP; Laycock ME; Mohr BA; Kalish LA; van der Horst CM; Antiviral Res; 2004 Aug; 63(2):123-31. PubMed ID: 15302141 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605 [TBL] [Abstract][Full Text] [Related]
13. Liver transplantation in HIV/hepatitis co-infection. Miro JM; Aguero F; Laguno M; Tuset M; Cervera C; Moreno A; Garcia-Valdecasas JC; Rimola A; J HIV Ther; 2007 Mar; 12(1):24-35. PubMed ID: 17589393 [TBL] [Abstract][Full Text] [Related]
14. Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection. Cooper CL; Mills E Int J STD AIDS; 2007 Aug; 18(8):546-50. PubMed ID: 17686217 [TBL] [Abstract][Full Text] [Related]
15. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Norris S; Taylor C; Muiesan P; Portmann BC; Knisely AS; Bowles M; Rela M; Heaton N; O'Grady JG Liver Transpl; 2004 Oct; 10(10):1271-8. PubMed ID: 15376307 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus and HIV coinfection: relationship of different serological patterns to survival and liver disease. Osborn MK; Guest JL; Rimland D HIV Med; 2007 Jul; 8(5):271-9. PubMed ID: 17561872 [TBL] [Abstract][Full Text] [Related]
17. HIV and hepatitis C co-infection: the role of HAART in HIV/hepatitis C virus management. Jones M; Núñez M Curr Opin HIV AIDS; 2011 Nov; 6(6):546-52. PubMed ID: 22001896 [TBL] [Abstract][Full Text] [Related]
18. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088 [TBL] [Abstract][Full Text] [Related]
19. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C; HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771 [TBL] [Abstract][Full Text] [Related]
20. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection. Vallet-Pichard A; Pol S J Hepatol; 2006; 44(1 Suppl):S28-34. PubMed ID: 16343684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]